Mobia Medical, Inc.
Research Mobia Medical, Inc. (MOBI) on Bullrun: market cap USD 286.26M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMOBI
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 286.26M
- Financial periodQ2 2026
- RevenueUSD 13.51M
- Net income-USD 21.04M
- Free cash flow-USD 17.21M
- Gross margin83.2%
Valuation Snapshot
latest market cap is USD 286.26M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 32.04M | -USD 46.50M | -USD 46.06M | 81.1% | -0.02 | USD 33.59M | USD 8.44M | -USD 150.77M |
| FY2024 | USD 15.64M | -USD 24.60M | -USD 24.36M | 79.6% | -1.08 | USD 14.62M | USD 7.72M | -USD 106.04M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 286.26M | n/a | n/a | n/a |
About Mobia Medical, Inc.
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Mobia Medical, Inc.'s market cap?
Mobia Medical, Inc.'s market capitalization is USD 286.26M.
What does Mobia Medical, Inc. do?
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients.